White Papers

GLP-1s are Changing Americans’ Bodies–But Not in the Way You Think

02/11/2026

Demand for GLP-1 agonists has been steadily climbing. From 2019 to 2023, the number of patients without diabetes who started GLP-1 treatment for obesity rose 700%; and demand for these ‘miracle’.

Weight Health at One Year: Outcomes from Omada's Enhanced GLP-1 Care Track

01/08/2026

Medication therapy and lifestyle support go hand in hand in obesity care, especially when we consider GLP-1s. The Omada Insights Lab evaluated outcomes in the Enhanced GLP-1 Care Track at one year,.

Weight Maintenance Is Possible After GLP-1s—With the Right Support

09/05/2025

Though evidence shows that GLP-1s are highly effective for weight loss, maintaining outcomes after GLP-1 discontinuation can be a struggle. Clinical trials indicate that people often regain a.

Webinars & Events

HLTH: 2026 Sponsor

02/24/2026

We’re proud to return as a sponsor of HLTH 2026 in Las Vegas. As the premier event for healthcare innovation, HLTH brings together more than 12,000 leaders, executives, and visionaries shaping the.

AHIP: 2026 Bronze Sponsor

02/24/2026

Omada Health is heading to Las Vegas for AHIP 2026, the industry’s flagship conference. This premier event brings together leaders, innovators, and change-makers from across the health insurance.

NEBGH: 2026 Silver Sponsor

02/24/2026

Join us for the NEBGH 15th Annual Health and Wellness Benefits Conference. This premier regional conference brings together employers, benefits leaders, and innovators to explore forward-thinking.

Keep Browsing

See All Posts
Become an Omada Insider
Sign Up